Professor of Diabetes Research, Professor Atkinson was part of one of the first group of researchers to identify the value of measuring immune responses against GAD in persons with type 1 diabetes. Professor Atkinson's research extends to understanding the immunological mechanisms underlying the formation of diabetes, with his primary research goal involving the development of an effective method for preventing and reversing type 1 diabetes. Professor Atkinson has been a member of the Scientific and Medical Advisory Board since 1997, and is a Board member in Diamyd Medical since 2018.

Associate Professor of Pediatrics at Indiana University (IU) School of Medicine, a pediatric endocrinologist at Riley Hospital for Children, and a physician scientist at the IU Center for Diabetes and Metabolic Diseases and the Herman B Wells Center for Pediatric Research. Dr. Sims' work focuses on identifying risk factors that predispose individuals to Type 1 Diabetes and developing innovative treatments to prevent or slow disease progression. Dr. Sims has been a member of the Scientific and Medical Advisory Board since 2024.

Associate Member and Principal Investigator at the Center for Translational Immunology at Benaroya Research Institute. Dr. Long's translational immunology lab investigates the mechanisms behind the loss of immune tolerance in autoimmune diseases and explores therapeutic strategies to restore it, including factors that influence differential responses to therapy among patients. Dr. Long has been a member of the Scientific and Medical Advisory Board since 2025.

Professor in Experimental Diabetes Research, Professor Lernmark has focused his research on diabetes and at an early stage identified the antigen that later proved to be GAD. He and his colleagues were the first to clone GAD65 from human islets using biochemical methods,and was thus the first to define autoantibodies against GAD65 in patients with type 1 diabetes. Professor Lernmark was first to use molecular methods to identify HLA genes that are necessary to develop the disorder. Professor Lernmark has been a member of the Scientific and Medical Advisory Board since 1996.

Professor of Diabetes and Autoimmunity. Professor Leslie has been Director of the British Diabetic Twin Study since 1982, the world's largest twin study of its type and Principal Investigator of the European Action LADA consortium. By studying twins, Professor Leslie has been able to show the possibilities for predicting and preventing autoimmune diabetes. Professor Leslie has been a member of the Scientific and Medical Advisory Board since 1999.